Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions (Q21004109)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions |
scientific article |
Statements
Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions (English)
0 references
Alastair J King
2 references
Marc R Arnone
2 references
Maureen R Bleam
2 references
Katherine G Moss
2 references
Jingsong Yang
2 references
Kelly E Fedorowicz
2 references
Kimberly N Smitheman
2 references
Joseph A Erhardt
2 references
Angela Hughes-Earle
2 references
Laurie S Kane-Carson
2 references
Robert H Sinnamon
2 references
Hongwei Qi
2 references
Tara R Rheault
2 references
David E Uehling
2 references
Sylvie G Laquerre
2 references
2013
0 references
8
0 references
7
0 references
e67583
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference